JOYCE BRUN: Open Payments
NPI 1780080200 · LATROBE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 22 payments from 12 companies in 2025. Trend: 2023 $100 · 2024 $119 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $70 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $65 |
| Amgen Inc. | 3 | $54 |
| UCB, Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| REVANCE THERAPEUTICS, INC. | 1 | $30 |
| Janssen Biotech, Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $20 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
Products named: ILUMYA, OTEZLA, COSENTYX, Bimzelx, DUPIXENT, DAXXIFY, AXERT, TALTZ.
Industry payments across PA — which companies pay providers there.
